Literature DB >> 17601901

Sociodemographic factors associated with high-risk human papillomavirus infection.

Jessica A Kahn1, Dongmei Lan, Robert S Kahn.   

Abstract

OBJECTIVE: To determine the prevalence of high-risk (cancer-associated) human papillomavirus (HPV) infection in U.S. women, identify sociodemographic factors associated with infection, and explore the implications for prevention of HPV-related disease in the vaccination era.
METHODS: Women aged 14-59 years (n=1,921) participating in the 2003-2004 National Health and Nutrition Examination Survey provided a vaginal swab which was evaluated for 37 HPV types. We determined which sociodemographic characteristics were associated with high-risk HPV, using logistic regression models.
RESULTS: High-risk HPV infection was present in 15.6% (95% confidence interval [CI] 12.6-18.6%) of participants, corresponding to a population prevalence of 12,028,293 U.S. women. Women living below the poverty line, compared with those living three or more times above it, were more likely to be positive for high-risk HPV (23% versus 12%, P = .03). Among participants living below the poverty line, only Mexican-American ethnicity (odds ratio [OR] 0.4, 95% CI 0.2-0.9) and unmarried status (OR 3.3, 95% CI 1.2-8.9) were associated with HPV prevalence. In contrast, several factors were associated with HPV among participants living above the poverty line, including black race (OR 1.4, 95% CI 1.0-2.0), income (OR 0.92, 95% CI 0.84-0.99), unmarried status (OR 2.0, 95% CI 1.3-3.0), and age (OR for 22-25 year olds 2.4, 95% CI 1.4-4.0).
CONCLUSION: High-risk HPV infection is common in U.S. women, particularly in poor women. Cervical cancer prevention efforts in the vaccination era must ensure that all low-income women have access to preventive services including education, Pap test screening, and HPV vaccines. Otherwise, existing disparities in cervical cancer could worsen.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17601901     DOI: 10.1097/01.AOG.0000266984.23445.9c

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.661


  64 in total

1.  Acculturation and HPV infection among Latinas in the United States.

Authors:  D Kepka; G Coronado; H Rodriguez; B Thompson
Journal:  Prev Med       Date:  2010-06-09       Impact factor: 4.018

2.  A national study of HPV vaccination of adolescent girls: rates, predictors, and reasons for non-vaccination.

Authors:  Laura M Kester; Gregory D Zimet; J Dennis Fortenberry; Jessica A Kahn; Marcia L Shew
Journal:  Matern Child Health J       Date:  2013-07

3.  Vaccine-type human papillomavirus and evidence of herd protection after vaccine introduction.

Authors:  Jessica A Kahn; Darron R Brown; Lili Ding; Lea E Widdice; Marcia L Shew; Susan Glynn; David I Bernstein
Journal:  Pediatrics       Date:  2012-07-09       Impact factor: 7.124

4.  Biopower, Normalization, and HPV: A Foucauldian Analysis of the HPV Vaccine Controversy.

Authors:  Kimberly S Engels
Journal:  J Med Humanit       Date:  2016-09

Review 5.  Human papillomavirus vaccines launch a new era in cervical cancer prevention.

Authors:  Meenakshi Dawar; Shelley Deeks; Simon Dobson
Journal:  CMAJ       Date:  2007-08-28       Impact factor: 8.262

6.  Adherence to conservative management recommendations for abnormal pap test results in adolescents.

Authors:  Rebecca B Perkins; Jennifer R Jorgensen; Molly E McCoy; Sharon M Bak; Tracy A Battaglia; Karen M Freund
Journal:  Obstet Gynecol       Date:  2012-06       Impact factor: 7.661

7.  Sexual behaviors and sexually transmitted infections in a nationally representative sample of women veterans and nonveterans.

Authors:  Keren Lehavot; Jodie G Katon; Emily C Williams; Karin M Nelson; Carolyn M Gardella; Gayle E Reiber; Tracy L Simpson
Journal:  J Womens Health (Larchmt)       Date:  2013-12-13       Impact factor: 2.681

8.  Are HPV vaccination services accessible to high-risk communities? A spatial analysis of HPV-associated cancer and Chlamydia rates and safety-net clinics.

Authors:  Jennifer Tsui; Hector P Rodriguez; Gilbert C Gee; Loraine A Escobedo; Gerald F Kominski; Roshan Bastani
Journal:  Cancer Causes Control       Date:  2013-09-17       Impact factor: 2.506

Review 9.  Integrating clinical, community, and policy perspectives on human papillomavirus vaccination.

Authors:  María E Fernández; Jennifer D Allen; Ritesh Mistry; Jessica A Kahn
Journal:  Annu Rev Public Health       Date:  2010       Impact factor: 21.981

10.  Distribution of Vaccine-Type Human Papillomavirus Does Not Differ by Race or Ethnicity Among Unvaccinated Young Women.

Authors:  Dana Whittemore; Lili Ding; Lea E Widdice; Darron A Brown; David I Bernstein; Eduardo L Franco; Jessica A Kahn
Journal:  J Womens Health (Larchmt)       Date:  2016-10-18       Impact factor: 2.681

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.